PELVIc Floor Evaluation live TRACKing – Real-time prediction of perineal trauma
PELVITRACK aims to prevent pelvic floor disorders by developing a real-time monitoring solution for perineal tearing during vaginal deliveries through interdisciplinary research and innovative technologies.
Projectdetails
Introduction
Pelvic tissues, supporting the pelvic floor, can change in physical properties during a lifetime, leading to dysfunctions commonly known as Pelvic Floor Disorders (PFDs). These disorders, encompassing pelvic pain, pelvic organ prolapses, urinary or anal incontinence, or dyspareunia, affect 32% of females and 16% of males worldwide, making it a major health concern.
Contributing Factors
Various factors such as older age, menopause, obesity, or intense physical activity are significant contributors to PFDs. However, the occurrence of PFDs is mainly due to traumatic events. Indeed, perineal tears, taking place in 90% of vaginal deliveries (VDs), have been identified as a high-risk factor for PFDs.
Project Overview
As an answer, PELVITRACK’s ambition is to enable the systematic prevention of PFDs, ensuring earlier diagnosis, more reliable prognosis, and more efficient care. More specifically, the project will design a real-time turnkey lab-scale solution to monitor perineal tearing during VD and minimize pelvic traumas.
Methodology
This revolution in the monitoring of the pelvic floor will be achieved through a hybrid experimental and numerical approach, leveraging ex vivo data and computational modelling on pig perineum to select IDEVs (Investigated DEVices) that will be adapted and validated in vivo on animals (preclinical study) and women (clinical studies).
Consortium
To achieve its ambitious goal, PELVITRACK gathers a unique interdisciplinary consortium of 11 partners, including renowned research institutions, universities, hospitals, and SMEs, to cover all the required scientific expertise and knowledge in:
- Mechanics
- Computer science
- Electrical and thermal engineering
- Acoustics
- Optics
- Obstetric physics
Conclusion
Exploring new technologies to predict perineal trauma in real time, PELVITRACK delineates a high-risk/high-gain proposal that will significantly contribute to the health and well-being of females in Europe and beyond.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.209.102 |
Totale projectbegroting | € 3.209.102 |
Tijdlijn
Startdatum | 1-4-2025 |
Einddatum | 31-3-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- INSTITUT MINES-TELECOMpenvoerder
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE
- CENTRE HOSPITALIER REGIONAL DE MARSEILLE ASSISTANCE PUBLIQUE-HOPITAUX MARSEILLE
- UNIVERSIDAD DE ZARAGOZA
- POLITECNICO DI TORINO
- ZAPADOCESKA UNIVERZITA V PLZNI
- INEGI - INSTITUTO DE CIENCIA E INOVACAO EM ENGENHARIA MECANICA E ENGENHARIA INDUSTRIAL
- VIRTUALCARE, LDA
- Superviseme LTD
- CENTRE HOSPITALIER UNIVERSITAIRE
- ECOLE NATIONALE SUPERIEURE DES MINES DE PARIS
- CENTRALE LILLE INSTITUT
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Smart Electronic Olfaction for Body Odor DiagnosticsSMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning. | EIC Pathfinder | € 3.263.781 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Smart Electronic Olfaction for Body Odor Diagnostics
SMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A completely biological and human tissue-engineered mesh produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Pelvic Organ Prolapse (POP)This project aims to develop a biological, tissue-engineered mesh using Cell-Assembled extracellular Matrix to treat Pelvic Organ Prolapse, demonstrating its safety and effectiveness in preclinical models. | ERC POC | € 150.000 | 2023 | Details |
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary IncontinenceDeveloping UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity. | EIC Accelerator | € 2.499.999 | 2023 | Details |
The first non-surgical repair for Pelvic Organ ProlapseEscala Medical's Apyx aims to provide a minimally invasive solution for early-stage pelvic organ prolapse, enhancing quality of life and preventing condition progression through clinical trials and commercialization. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour casesINNITIUS aims to optimize TPTL diagnosis with Fine Birth, a non-invasive AI-driven device that assesses cervical tissue consistency, seeking €2.5M for further development and regulatory approval. | EIC Accelerator | € 2.342.835 | 2023 | Details |
A completely biological and human tissue-engineered mesh produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Pelvic Organ Prolapse (POP)
This project aims to develop a biological, tissue-engineered mesh using Cell-Assembled extracellular Matrix to treat Pelvic Organ Prolapse, demonstrating its safety and effectiveness in preclinical models.
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary Incontinence
Developing UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity.
The first non-surgical repair for Pelvic Organ Prolapse
Escala Medical's Apyx aims to provide a minimally invasive solution for early-stage pelvic organ prolapse, enhancing quality of life and preventing condition progression through clinical trials and commercialization.
Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour cases
INNITIUS aims to optimize TPTL diagnosis with Fine Birth, a non-invasive AI-driven device that assesses cervical tissue consistency, seeking €2.5M for further development and regulatory approval.